Agustí, A., Rapsomaniki, E., Beasley, R., Hughes, R., Müllerová, H., Papi, A., Pavord, I. D., van den Berge, M., Faner, R. & for the NOVELTY Study Investigators (2022).
Treatable traits in the NOVELTY study.
Respirology,
27(11), 929-940.
https://doi.org/10.1111/resp.14325
Andersen, K. H., Iversen, M. J., Kjaergaard, J., Mortensen, J.
, Nielsen-Kudsk, J. E., Bendstrup, E., Videbaek, R. & Carlsen, J. (2012).
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
31(4), 373–380.
https://doi.org/10.1016/j.healun.2011.11.020
Antoniou, K. M., Trachalaki, A., Tzouvelekis, A.
, Poletti, V., Vasarmidi, E., Sfikakis, P. & Bouros, D. (2020).
A role of antifibrotics in the treatment of Scleroderma-ILD? Pulmonology,
26(1), 1-2.
https://doi.org/10.1016/j.pulmoe.2019.08.004
Antoniou, K. M., Vasarmidi, E., Russell, A. M., Andrejak, C., Crestani, B., Delcroix, M., Dinh-Xuan, A. T.
, Poletti, V., Sverzellati, N., Vitacca, M., Witzenrath, M., Tonia, T. & Spanevello, A. (2022).
European Respiratory Society statement on long COVID follow-up.
European Respiratory Journal,
60(2), Article 2102174.
https://doi.org/10.1183/13993003.02174-2021